Optical tomography as adjunct to X-ray mammography: Methods and results

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6431, Issue , 2007, Pages

  Khayat, Mario ^a   Ichalalene, Zahia ^a   Mincu, Niculae ^a   Leblond, Fredéric ^a   Guilman, Olga ^a   Djeziri, Salim ^a  

^a ART Advanced Research Technologies Inc   (Canada)

Author keywords

Optical tomography breast cancer; Time domain; X ray mammography

Indexed keywords

ALGORITHMS; BIOMEDICAL ENGINEERING; CHROMOPHORES; MEDICAL IMAGING; ONCOLOGY; OPTICAL TOMOGRAPHY; TISSUE;

OPTICAL IMAGING; OPTICAL TOMOGRAPHY BREAST CANCER; TIME DOMAIN ACQUISITION SYSTEM; X-RAY MAMMOGRAPHY;

MAMMOGRAPHY;

EID: 34247362060     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.700960     Document Type: Conference Paper

References (31)

1. http://www.who.int/mediacentre/factsheets/fs297/en/index.html
2. Elmore, J.G. MD, MPH; Armstrong, K. MD; Lehman, C.D. MD, PhD; Fletcher, S.W. MD, MSc: Screening for Breast Cancer, JAMA. 2005:293:1245-1256.
3. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137(5 Part 1): 347-360.
4. Duffy SW, Tabar L, Tony H.H. Chen et al.:Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data. Cancer Epidemiol Biomarkers Prev 2006;15(1):45-51.
5. Zackrisson S, Andersson J, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006:332: 689-91.
6. Lucassen A, Watson E and Eccles D: 2004 Advice about mammography for a young woman with a family history of breast cancer Br. Med. J. 322 1040-2.
7. Irwig, L, Macaskill, P, Walter, S, Houssami, N.: New methods give better estimates of changes in diagnostic accuracy when prior information is provided. Journal of clinical epidemiology 2006; 59:299-307.
8. Barlow WE et. Al.: Performance of Diagnostic Mammography for Women With Signs or Symptoms of Breast Cancer Journal of the National Cancer Institute, Vol. 94, No. 15, August 7, 2002
9. Eubank WB, Mankoff DA: Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 2005, 35:84-99
10. Walter C. Scheidhauer WC, et al. Clinical Diagnostic Value of Preoperative MR Mammography and FDG-PET in suspicious breast lesions. Eur Radiol 2003;13(7): 1651-1666.
11. Ntziachristos V, Chance B: Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res 2001, 3:41-46.
12. Rice A and Quinn C M: Angiogenesis, thrombospodin, and ductal carcinoma in situ of the breast. J. Clin. Pathol. 2002; 55 569-74.
13. P. Vaupel, A. Mayer, S. Briest, and M. Hockel. Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res. 63, 7634-7637 (2003).
14. Grosenick D, Moesta KT, et al: Time-domain optical mammography: initial clinical results on detection and characterization of breast tumors. Applied Optics 2003; 42:3170-3186.
15. D. Grosenick et al., Concentration and oxygen saturation of haemoglobin of 50 breast tumours determined by time-domain optical mammography, Phys. Med. Biol. 49, 1165-1181 (2004).
16. B. Pogue et al., Quantitative Hemoglobin Tomography with Diffuse Near-Infrared Spectroscopy: Pilot Results in the Breast, Radiology 2001, 218:261-266 (2001).
17. X. Intes et al, Time Domain Optical Mammography SoftScan: Initial Results, Acad Radial 2005; 12:934-947.
18. D. Contini et al., Photon migration through a turbid slab described by a model based on diffusion approximation. Theory, Appl. Opt. 36, 4587-4599 (1997).
19. S. R. Arridge, Photon measurement density functions, Part I : analytical forms, Appl. Opt. 34, 7395-7409 (1995).
20. http://omlc.ogi.edu/spectra/
21. S. Srinivasan et al., Near-Infrared Characterization of Breast Tumors In Vivo using Spectrally-Constrained Reconstruction, Technology in Cancer Research and Treatment 4, 513-526 (2005).
22. A. Corlu et al., Diffuse optical tomography with spectral constraints and wavelength optimization, Appl. Opt. 44, 2082-2093 (2005).
23. Van Staveren HJ, Moes CJM, van Marle J, Prahl SA and van Germet JC. Ligth scattering in intralipid-10% in the wavelength range of 400-1100nm.Appl. Opt. (1991);30:4507-4514.
24. J. R. Mourant, T. Fuselier, J. Boyer, T. M. Johnson, and I. J. Bigio. Predictions and measurements of scattering and absorption over broad wavelength ranges in tissue phantoms. Appl.Opt. 39, 949-957 (1997).
25. Cerussi A, Berger A, Bevilacqua F, Shah N, Jakubowski D, Butler J, Holcombe FR and Tromberg B. Sources of absorption and scattering contrast for near-infrared optical mammography. Acad. Radiology 2001; 8:211-218
26. P. Taroni, A. Pifferi, A. Torricelli, D. Comelli, and R. Cubeddu. In vivo absorption and scattering spectroscopy of biological tissues. Photoch. Photobio. Sci. 2(2), 124-129 (2003).
27. B. Pogue et al., Characterization of hemoglobin, water, and NIR scattering in breast tissue: analysis of intersubject variability and menstrual cycle changes, Journal of Biomedical Optics. 9(3), 541-552 (2004).
28. B.J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, "Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy." Neoplasia (New York), vol. 2(1-2) pp. 26-40.2000.
29. Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities: Executive Summary. No. 2 (AHRQ Pub. No. 06-EHC005-1), February 2006.
30. Warner E., MD; Plewes, D. B. PhD; et al: Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination, JAMA. 2004;292:1317-1325.
31. Houssami, N; Irwig, L.; et al.: The influence of clinical information on the accuracy of diagnostic mammography. Breast Cancer Research and Treatment, Volume 85, Number 3, June 2004, pp. 223-228(6)